ATE417926T1 - Zusammensetzungen zur modulierung der länge von telomeren - Google Patents

Zusammensetzungen zur modulierung der länge von telomeren

Info

Publication number
ATE417926T1
ATE417926T1 AT97928088T AT97928088T ATE417926T1 AT E417926 T1 ATE417926 T1 AT E417926T1 AT 97928088 T AT97928088 T AT 97928088T AT 97928088 T AT97928088 T AT 97928088T AT E417926 T1 ATE417926 T1 AT E417926T1
Authority
AT
Austria
Prior art keywords
telomeres
length
compositions
relates
hnrnp
Prior art date
Application number
AT97928088T
Other languages
English (en)
Inventor
Benoit Chabot
Original Assignee
Gemin X Pharmaceuticals Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gemin X Pharmaceuticals Canada filed Critical Gemin X Pharmaceuticals Canada
Application granted granted Critical
Publication of ATE417926T1 publication Critical patent/ATE417926T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
  • Liquid Crystal Substances (AREA)
AT97928088T 1996-07-01 1997-06-30 Zusammensetzungen zur modulierung der länge von telomeren ATE417926T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2095696P 1996-07-01 1996-07-01

Publications (1)

Publication Number Publication Date
ATE417926T1 true ATE417926T1 (de) 2009-01-15

Family

ID=21801513

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97928088T ATE417926T1 (de) 1996-07-01 1997-06-30 Zusammensetzungen zur modulierung der länge von telomeren

Country Status (8)

Country Link
US (2) US6294332B1 (de)
EP (1) EP0909317B1 (de)
AT (1) ATE417926T1 (de)
AU (1) AU3251597A (de)
CA (1) CA2259389A1 (de)
DE (1) DE69739167D1 (de)
ES (1) ES2319238T3 (de)
WO (1) WO1998000537A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2264262A1 (en) * 1999-03-25 2000-09-25 Benoit Chabot Composition and methods for modulating the length of telomeres
EP1103615A1 (de) * 1999-11-25 2001-05-30 Universite De Geneve Vektoren, die nicht-teilende Zellen immortalisieren können und Zellen, die mit diesen Vektoren immortalisiert wurden
AUPQ525500A0 (en) * 2000-01-25 2000-02-17 Technological Resources Pty Limited A method of relining a vessel
EP1511844A2 (de) * 2002-05-30 2005-03-09 Télogéne Inc., Institut de Pharmacologie Verfahren und zusammensetzungen zur behandlung von neoplasien, die hnrnp a1 und hnrnp a2 nucleinsäuremoleküle betreffen
US20050113324A1 (en) * 2003-01-15 2005-05-26 Bondarev Igor E. Modulation of line-1 reverse transcriptase
RU2407509C2 (ru) * 2004-09-06 2010-12-27 Общество с ограниченной ответственностью "Санкт-Петербургский институт красоты" Косметическое средство и способ его получения
US8307489B1 (en) 2009-07-24 2012-11-13 Ronald Adame Towel assembly
US20130210901A1 (en) * 2010-09-20 2013-08-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of treating neurodegenerative diseases
CN116854774B (zh) * 2023-03-27 2023-12-29 徐灵胎中医药研究(佛山)有限公司 衍生肽、端粒长度调节剂及其在抗衰老中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5489508A (en) 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
WO1995013383A1 (en) 1993-11-12 1995-05-18 Geron Corporation Methods and reagents for lengthening telomeres
US5583016A (en) * 1994-07-07 1996-12-10 Geron Corporation Mammalian telomerase
US5972605A (en) 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
US5741677A (en) 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
US5733730A (en) 1995-08-25 1998-03-31 The Rockefeller University Telomere repeat binding factor and diagnostic and therapeutic use thereof
US5856096A (en) 1995-09-20 1999-01-05 Ctrc Research Foundation Rapid and sensitive assays for detecting and distinguishing between processive and non-processive telomerase activities
US5994062A (en) * 1995-10-02 1999-11-30 The United States Of America As Represented By The Department Of Health And Human Services Epithelial protein and DNA thereof for use in early cancer detection
EP0953042A1 (de) 1996-09-13 1999-11-03 Geron Corporation Verfahren und reagentien zur regulation der telomerenlänge und der telomerase-aktivität

Also Published As

Publication number Publication date
US20020114797A1 (en) 2002-08-22
DE69739167D1 (de) 2009-01-29
US6294332B1 (en) 2001-09-25
AU3251597A (en) 1998-01-21
ES2319238T3 (es) 2009-05-05
WO1998000537A1 (en) 1998-01-08
CA2259389A1 (en) 1998-01-08
EP0909317B1 (de) 2008-12-17
EP0909317A1 (de) 1999-04-21

Similar Documents

Publication Publication Date Title
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
UA74325C2 (uk) ГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ р38, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЇХ МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ ЗА ЇХ ДОПОМОГОЮ
DE69830404D1 (de) P38-inhibitoren
ATE230394T1 (de) Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
BR9714415A (pt) Heterociclos contendo nitrogênio substituìdo como inibidores de proteìnas quinase p38
BG104356A (en) Compounds based on azabenzimidazole for the modulation of serin/treonin protein kinase function
BR0016166A (pt) Compostos de diidropirimidina heterocìclicos
MY117696A (en) INHIBITORS OF p38
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
PE14199A1 (es) Agonistas de 5-ht1f
BR0010220A (pt) Compostos de pirimidinona
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BR0316296A (pt) Compostos lapacone e seus métodos de uso
DE69934998D1 (de) Antisense modulation der expression von integrin alpha 4
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
MY101520A (en) Indoline and 2-indolinone derivatives.
EP1244452A4 (de) Urotensin-ii rezeptorantagonisten
DE69739167D1 (de) Zusammensetzungen zur modulierung der länge von telomeren
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
NO892125D0 (no) Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler.
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
DE69835828D1 (de) Muc-1 derivate und deren verwendung zur behandlung von krebsassoziierter muc-1 mucin induzierter immunosuppression
BR0113266A (pt) Métodos para modular proteìnas quinase de linhagem múltipla e compostos protetores que modulam proteìnas quinase de linhagem múltipla

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties